Difference between revisions of "Tasian SK, et al. Front. Oncol. (2014) cited as Ref 352 in DOI: 10.1038/s41392-020-0110-5 (Q9615)"
Jump to navigation
Jump to search
(Created claim: First Author string (P149): Tasian SK, #quickstatements; #temporary_batch_1589996169159) |
(Created claim: Page(s) (P105): 108-, #quickstatements; #temporary_batch_1590074839150) |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / Second Author string | |||||||||||||||
| + | Teachey DT | ||||||||||||||
| Property / Second Author string: Teachey DT / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Third Author string | |||||||||||||||
| + | Rheingold SR | ||||||||||||||
| Property / Third Author string: Rheingold SR / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / PubMed ID | |||||||||||||||
| + | |||||||||||||||
| Property / PubMed ID: 24904824 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2014
| ||||||||||||||
| Property / Publication Date: 2014 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Published In Name String | |||||||||||||||
| + | Front. Oncol. | ||||||||||||||
| Property / Published In Name String: Front. Oncol. / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Volume | |||||||||||||||
| + | 4 | ||||||||||||||
| Property / Volume: 4 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / title | |||||||||||||||
| + | Targeting the PI3K/mTOR pathway in pediatric hematologic malignancies (English) | ||||||||||||||
| Property / title: Targeting the PI3K/mTOR pathway in pediatric hematologic malignancies (English) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Page(s) | |||||||||||||||
| + | 108- | ||||||||||||||
| Property / Page(s): 108- / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Latest revision as of 15:38, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Tasian SK, et al. Front. Oncol. (2014) cited as Ref 352 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Tasian SK
0 references
Teachey DT
0 references
Rheingold SR
0 references
2014
0 references
Front. Oncol.
0 references
4
0 references
Targeting the PI3K/mTOR pathway in pediatric hematologic malignancies (English)
0 references
108-
0 references
